Clarington Peptides / Archive6 articles

All Articles

01
alcohol cue reactivity
5 min read

Semax for Alcohol Cue Reactivity: Can This Nootropic Peptide Reduce Craving Triggers?

Exploring whether the nootropic peptide Semax could reduce alcohol cue reactivity, in light of the VA's GLP-1 trial for AUD. A look at BDNF, dopamine

02
brain fog
9 min read

P21 for Cognitive Fog During GLP-1 Dose Titration

P21 is a synthetic peptide that may promote neurogenesis, but can it ease the cognitive fog some people experience when adjusting to GLP-1 drugs like

03
cancer treatment
7 min read

P21 for Chemo Brain: Can This Nootropic Peptide Restore Cognitive Function After Cancer Treatment Amid the FDA Panel’s Peptide Review?

P21 is a nootropic peptide with animal data suggesting it could help chemo brain, but no human trials exist. We examine the mechanisms, gaps, and what

04
anxiety
4 min read

Semax vs. P21 for Focus and Anxiety: The FDA Peptide Panel Vote

Semax and P21 are two synthetic peptides studied for focus and anxiety, but human data is scarce. The FDA peptide panel vote could reshape nootropic

05
cognitive clarity
6 min read

P21 for Post-COVID Brain Fog: Can This Nootropic Peptide Restore Cognitive Clarity?

Post-COVID brain fog affects millions, and the nootropic peptide P21 is gaining attention for cognitive repair. We examine the preclinical evidence, gaps

06
BDNF
6 min read

Semax and P21 for Post-Stroke Cognitive Rehabilitation

Semax and P21 are peptides studied for post-stroke neuroplasticity. This article examines the preclinical evidence, mechanistic rationale, and translational